Putnam Investments LLC Vor Biopharma Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$11.32 - $18.02 $2.7 Million - $4.3 Million
-238,438 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$12.24 - $20.38 $3.81 Million - $6.35 Million
-311,562 Reduced 56.65%
238,438 $3.74 Million
Q1 2021

May 17, 2021
BUY
$30.96 - $54.08 $17 Million - $29.7 Million
550,000 New
550,000 $23.7 Million

Others Institutions Holding VOR

# of Institutions
57
Shares Held
41.2M
Call Options Held
9.3K
Put Options Held
100
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $63.2M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email